GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » YoY EBITDA Growth

BeyondSpring (BeyondSpring) YoY EBITDA Growth : 100.00% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. BeyondSpring's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 100.00%.

BeyondSpring's EBITDA per Share for the three months ended in Dec. 2023 was $0.00.


BeyondSpring YoY EBITDA Growth Historical Data

The historical data trend for BeyondSpring's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring YoY EBITDA Growth Chart

BeyondSpring Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.87 -30.65 22.14 44.46 39.87

BeyondSpring Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.89 100.00 100.00 100.00 100.00

BeyondSpring YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

BeyondSpring's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.552--0.918)/ | -0.918 |
=39.87 %

BeyondSpring's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2021 )) / | EBITDA per Share (Q: Dec. 2021 )) |
=(0--0.249)/ | -0.249 |
=100.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BeyondSpring YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of BeyondSpring's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


BeyondSpring (BeyondSpring) Business Description

Traded in Other Exchanges
N/A
Address
28 Liberty Street, 39th Floor, New York, NY, USA, 10005
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.

BeyondSpring (BeyondSpring) Headlines

From GuruFocus

BeyondSpring Files 2022 Annual Report on Form 20-F

By sperokesalga sperokesalga 04-18-2023